Related Experiment Video

Updated: Jun 6, 2026

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns

J Wells Logan1, T Michael O'Shea, Elizabeth N Allred

  • 1New Hanover Regional Medical Center, Wilmington, North Carolina, USA. wells.logan@ccneo.net

Archives of Disease in Childhood. Fetal and Neonatal Edition
|December 9, 2010
PubMed

Insights

Early hypotension indicators in extremely low gestational age newborns were not linked to developmental delay at 24 months. This study found no significant association between low blood pressure and later cognitive or motor impairments.

Area of Science:

  • Neonatalogy
  • Developmental Pediatrics
  • Critical Care Medicine

Background:

  • Extremely low gestational age newborns are at high risk for adverse neurodevelopmental outcomes.
  • Hypotension in the first 24 postnatal hours is a concern in this vulnerable population.
  • Understanding the relationship between early hemodynamic instability and later development is crucial for clinical management.

Purpose of the Study:

  • To investigate the association between indicators of hypotension in the first 24 postnatal hours and developmental delay at 24 months corrected age in extremely low gestational age newborns.
  • To assess the impact of specific hypotension indicators: low mean arterial pressure, vasopressor treatment, and blood pressure lability.
  • To determine if these early hemodynamic factors predict cognitive and psychomotor development.

Main Methods:

  • Prospective study of 945 infants born at <28 weeks gestation.
  • Assessment of three hypotension indicators within 24 postnatal hours.
  • Evaluation of cognitive (Mental Development Index) and psychomotor (Psychomotor Development Index) outcomes at 24 months corrected age using the Bayley Scales.
  • Logistic regression analysis adjusted for confounders.

Main Results:

  • 78% of infants received volume expansion or vasopressor treatment.
  • 26% had a Mental Development Index <70 and 32% had a Psychomotor Development Index <70.
  • After adjusting for confounders, none of the assessed hypotension indicators were significantly associated with developmental delay (MDI <70 or PDI <70).

Conclusions:

  • In a large cohort of extremely low gestational age newborns, early postnatal hypotension indicators showed little evidence of association with developmental delay at 24 months corrected age.
  • Gestational age was a significant factor associated with both vasopressor treatment and developmental outcomes.
  • Further research may be needed to explore other potential predictors of neurodevelopmental delay in this population.
Abstract

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...